Tenofovir Disoproxil Fumarate v. Emtricitabine for Hep B

ID Number 07-0808

Principal Investigator(s)
Lawrence Liu

Department(s) or Division(s)
Liver Diseases


The purpose of this study is to compare the safety, effectiveness, and how well study subjects can handle taking 48 weeks of study medication of tenofovir DF (TDF) taken once daily by itself versus emtricitabine (FTC) plus tenofovir DF taken together once daily.

Contact Information
Nita Bhatia
(212) 241-8903

Recruiting Patients: No